首页> 外文会议>Pacific Symposium on Biocomputing >Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression~1
【24h】

Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression~1

机译:对PRWAS关联优先考虑的预测和预测基因表达的评估〜1

获取原文
获取外文期刊封面目录资料

摘要

Genome-wide association studies (GWAS) have been successful in facilitating the understanding of genetic architecture behind human diseases, but this approach faces many challenges. To identify disease-related loci with modest to weak effect size, GWAS requires very large sample sizes, which can be computational burdensome. In addition, the interpretation of discovered associations remains difficult. PrediXcan was developed to help address these issues. With built in SNP-expression models, PrediXcan is able to predict the expression of genes that are regulated by putative expression quantitative trait loci (eQTLs), and these predicted expression levels can then be used to perform gene-based association studies. This approach reduces the multiple testing burden from millions of variants down to several thousand genes. But most importantly, the identified associations can reveal the genes that are under regulation of eQTLs and consequently involved in disease pathogenesis. In this study, two of the most practical functions of PrediXcan were tested: 1) predicting gene expression, and 2) prioritizing GWAS results. We tested the prediction accuracy of PrediXcan by comparing the predicted and observed gene expression levels, and also looked into some potential influential factors and a filter criterion with the aim of improving PrediXcan performance. As for GWAS prioritization, predicted gene expression levels were used to obtain gene-trait associations, and background regions of significant associations were examined to decrease the likelihood of false positives. Our results showed that 1) PrediXcan predicted gene expression levels accurately for some but not all genes; 2) including more putative eQTLs into prediction did not improve the prediction accuracy; and 3) integrating predicted gene expression levels from the two PrediXcan whole blood models did not eliminate false positives. Still, PrediXcan was able to prioritize GWAS associations that were below the genome-wi
机译:基因组 - 范围协会研究(GWA)已经成功地促进了对人类疾病背后遗传建筑的理解,但这种方法面临着许多挑战。为了将疾病相关的基因群与弱效应尺寸较弱,GWA需要非常大的样本尺寸,这可以是计算繁重。此外,发现的协会的解释仍然困难。 PredixCan是开发的,以帮助解决这些问题。通过内置的SNP表达模型,Predixcan能够预测通过推定的表达定量性状基因座(EQTLS)调节的基因的表达,然后可以使用这些预测的表达水平来进行基于基因的关联研究。这种方法将数百万变种降低到几千个基因的多重测试负担。但最重要的是,所识别的关联可以揭示正在调节EQTL的基因,并因此参与疾病发病机制。在这项研究中,测试了预测基因表达的两种最实际的功能,并且预测了GWAS结果的优先排序。我们通过比较预测和观察到的基因表达水平来测试Predixcan的预测准确性,并且还研究了一些潜在的影响因素和滤波标准,目的是提高Predixcan性能。对于GWAS优先化,使用预测的基因表达水平来获得基因 - 性状联想,并检查了重要关联的背景区域以降低误报的可能性。我们的研究结果表明,Predixcan预测基因表达水平,以便于某些但不是所有基因; 2)包括更多推定的EQTL进入预测,没有提高预测准确性; 3)将预测的基因表达水平与两种Predixcan全血模型相结合并未消除误报。尽管如此,Predixcan能够优先考虑基因组-WI以下的GWAS关联

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号